Self-monitoring weight for Weight Loss

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Weight Loss+3 MoreSelf-monitoring weight - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will examine three tracking strategies for weight loss delivered through digital health tools to see which combination is most effective.

Eligible Conditions
  • Weight Loss
  • Health Behaviors
  • Obesity

Treatment Effectiveness

Study Objectives

2 Primary · 7 Secondary · Reporting Duration: 1-, 3-, and 6-months

1-, 3-, and 6-months
Association between self- monitoring engagement and weight change
Retention rate
3- and 6-months
Clinically significant weight loss
baseline and 6 months
Caloric intake
baseline to 6 months
Engagement in other intervention components
Self-monitoring engagement
baseline, 1-, 3-, and 6-months
BMI
Body weight
baseline, 3-, and 6-months
Physical activity

Trial Safety

Trial Design

8 Treatment Groups

Condition 5
1 of 8
Condition 6
1 of 8
Condition 2
1 of 8
Condition 7
1 of 8
Condition 3
1 of 8
Condition 1
1 of 8
Condition 4
1 of 8
Condition 8
1 of 8

Experimental Treatment

176 Total Participants · 8 Treatment Groups

Primary Treatment: Self-monitoring weight · No Placebo Group · N/A

Condition 5Experimental Group · 3 Interventions: Core behavioral weight loss intervention, Self-monitoring steps, Self-monitoring weight · Intervention Types: Behavioral, Behavioral, Behavioral
Condition 6Experimental Group · 3 Interventions: Core behavioral weight loss intervention, Self-monitoring weight, Self-monitoring diet · Intervention Types: Behavioral, Behavioral, Behavioral
Condition 2Experimental Group · 2 Interventions: Core behavioral weight loss intervention, Self-monitoring weight · Intervention Types: Behavioral, Behavioral
Condition 7Experimental Group · 3 Interventions: Core behavioral weight loss intervention, Self-monitoring steps, Self-monitoring diet · Intervention Types: Behavioral, Behavioral, Behavioral
Condition 3Experimental Group · 2 Interventions: Core behavioral weight loss intervention, Self-monitoring steps · Intervention Types: Behavioral, Behavioral
Condition 1
Behavioral
Experimental Group · 1 Intervention: Core behavioral weight loss intervention · Intervention Types: Behavioral
Condition 4Experimental Group · 2 Interventions: Core behavioral weight loss intervention, Self-monitoring diet · Intervention Types: Behavioral, Behavioral
Condition 8Experimental Group · 4 Interventions: Core behavioral weight loss intervention, Self-monitoring steps, Self-monitoring weight, Self-monitoring diet · Intervention Types: Behavioral, Behavioral, Behavioral, Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 1-, 3-, and 6-months

Who is running the clinical trial?

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,148 Previous Clinical Trials
4,074,611 Total Patients Enrolled
90 Trials studying Weight Loss
17,424 Patients Enrolled for Weight Loss
Stanford UniversityLead Sponsor
2,170 Previous Clinical Trials
35,768,107 Total Patients Enrolled
11 Trials studying Weight Loss
1,690 Patients Enrolled for Weight Loss
Michele L Patel, PhDPrincipal InvestigatorStanford University

Eligibility Criteria

Age 18+ · All Participants · 7 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have a body mass index (BMI) of 25.0 to 45.0 kg/m^2.
English language proficiency is not a criterion for exclusion from the study.

Who else is applying?

What state do they live in?
Oregon33.3%
California33.3%
Florida33.3%
How old are they?
65+100.0%
What portion of applicants met pre-screening criteria?
Did not meet criteria66.7%
Met criteria33.3%
Why did patients apply to this trial?
  • "I’ve been interested in ACT for awhile now, but haven’t ever tried it."
How many prior treatments have patients received?
0100.0%